Thromb Haemost 2003; 90(04): 738-748
DOI: 10.1055/s-0037-1613622
New Technologies and Diagnotic Tools
Schattauer GmbH

Messenger RNA profiling of human platelets by microarray hybridization

Peter Bugert
1   Institute of Transfusion Medicine and Immunology, Red Cross Blood Service of Baden-Württemberg - Hessen, University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
,
Alex Dugrillon
1   Institute of Transfusion Medicine and Immunology, Red Cross Blood Service of Baden-Württemberg - Hessen, University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
,
Ayse Günaydin
1   Institute of Transfusion Medicine and Immunology, Red Cross Blood Service of Baden-Württemberg - Hessen, University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
,
Hermann Eichler
1   Institute of Transfusion Medicine and Immunology, Red Cross Blood Service of Baden-Württemberg - Hessen, University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
,
Harald Klüter
1   Institute of Transfusion Medicine and Immunology, Red Cross Blood Service of Baden-Württemberg - Hessen, University of Heidelberg, Faculty of Clinical Medicine Mannheim, Germany
› Author Affiliations
Financial support: This work was supported by the ‘Schwerpunktprogramm MIGROVAS’ of the Faculty of Clinical Medicine Mannheim, University of Heidelberg.
Further Information

Publication History

Received 03 February 2003

Accepted after revision 31 March 2003

Publication Date:
09 December 2017 (online)

Summary

Platelets are generally believed to be inactive in terms of de novo protein synthesis. On the other hand, the presence of ribosomes and mRNA molecules is well established. Many studies have used reverse transcriptase (RT) -PCR for detection of gene transcripts in platelets. As RT-PCR is a very sensitive method, any leukocyte contamination of platelet preparations can lead to false results. We performed three filtration procedures to minimize leukocyte contamination of pooled buffy-coat platelet concentrates prior to RNA isolation. Furthermore, by applying a genomic PCR approach with 50 amplification cycles we demonstrated that nucleated cells were not detectable. Microarray hybridization was used to analyze 9,850 individual human genes in RNA from purified platelets. In total we identified 1,526 (15.5%) positive genes. The data were confirmed in six individual experiments each performed on a PC pooled from four individual blood donations. Genes specific for nucleated blood cells such as CD4, CD83 and others were negative and verified the purity of PC. Overrepresentation of positive genes was found in the functional categories of glycoproteins/integrins (22.6% vs. 15.5%, p=0.029) and receptors (20.7% vs. 15.5%, p<0.001). Gene transcripts encoding RANTES, GRO-α, MIP-1α, MIP-1β, and others were found at high levels of signal intensity and confirmed literature data. This work provides a mRNA profile of human platelets and a complete list of results can be downloaded from the website of our institute www.ma.uni-heidelberg.de/inst/iti/plt_array.xls. The knowledge about gene transcripts may have an impact on the characterization of novel proteins and their functions in platelets.

 
  • References

  • 1 Ts’ao CH. Rough endoplasmatic reticulum and ribosomes in blood platelets. Scand J Haematol 1971; 8: 134-40.
  • 2 Booyse FM, Rafelson ME. Stable messenger RNA in the synthesis of contractile protein in human platelets. Biochim Biophys Acta 1967; 145: 188-90.
  • 3 Booyse FM, Rafelson ME. Studies on human platelets. I. Synthesis of platelet protein in a cell free system. Biochim Biophys Acta 1968; 166: 689-97.
  • 4 Bruce IJ, Kerry R. The effect of chloramphenicol and cycloheximide on platelet aggregation and protein synthesis. Biochem Pharmacol 1987; 36: 1769-73.
  • 5 Weyrich AS, Dixon DA, Pabla R. et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 1998; 95: 5556-61.
  • 6 Santoso S, Kalb R, Kiefel V. et al. The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis. Brit J Haematol 1993; 84: 451-6.
  • 7 Djaffar I, Vilette D, Bray PF. et al. Quantitative isolation of RNA from human platelets. Thromb Res 1991; 62: 127-35.
  • 8 Grabarek J, Raychowdhury M, Ravid K. et al. Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells. J Biol Chem 1992; 267: 10011-17.
  • 9 Newman PJ, Gorski J, White GC. et al. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest 1988; 82: 739-43.
  • 10 Wicki AN, Walz A, Gerber-Huber SN. et al. Isolation and characterization of human blood platelet mRNA and construction of a cDNA library in °gt11. Thromb Haemost 1989; 61: 448-53.
  • 11 Power CA, Clemetson JM, Clemetson KJ. et al. Chemokine and chemokine receptor mRNA in human platelets. Cytokine 1995; 7: 479-82.
  • 12 Bubel S, Wilhelm D, Entelmann M. et al. Chemokines in stored platelet concentrates. Transfusion 1996; 36: 445-9.
  • 13 Noordewier MO, Warren PV. Gene expression microarrays and the integration of biological knowledge. Trends Biotechnol 2001; 19: 412-5.
  • 14 Walker J, Flower D, Rigley K. Microarrays in hematology. Curr Opin Hematol 2002; 9: 23-9.
  • 15 Klüter H, Müller-Steinhardt M, Danzer S. et al. Cytokines in platelet concentrates prepared from pooled buffy coats. Vox Sang 1995; 69: 38-43.
  • 16 Christensen LL, Grunnet N, Rüdiger N. Comparison of the level of cytokine mRNA in buffy coat-derived platelet concentrates prepared with or without white cell reduction by filtration. Transfusion 1998; 38: 236-41.
  • 17 Stirling D, Hannant WA, Ludlam CA. Transcriptional activation of the factor VIII gene in liver cell lines by interleukin-6. Thromb Haemost 1998; 79: 74-8.
  • 18 Montefusco MC, Duga S, Asselta R. et al. A novel base pair deletion in the factor V gene associated with severe factor V deficiency. Brit J Haematol 2000; 111: 1240-6.
  • 19 Jandrot-Perrus M, Busfield S, Lagrue A. H. et al. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 2000; 96: 1798-1807.
  • 20 Nagai A, Nakagawa E, Choi HB. et al. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 2001; 60: 386-92.
  • 21 Smits HA, Rijsmus A, van Loon JH. et al. Amyloid-β-induced chemokine production in primary human macrophages and astrocytes. J Neuroimmunol 2002; 127: 160-8.
  • 22 Lindemann S, Tolley ND, Dixon DA. et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1β°synthesis. J Cell Biol 2001; 154: 485-90.
  • 23 Hartwig D, Härtel C, Hennig H. et al. Evidence for de-novo-synthesis of cytokines and chemokines in platelet concentrates. Vox Sang 2002; 82: 182-90.
  • 24 Martincic D, Kravtsov V, Gailani D. Factor XI messenger RNA in human platelets. Blood 1999; 94: 3397-3404.
  • 25 Dunstan RA, Simson MB, Rosse WF. Erythrocyte antigens on human platelets. Absence of Rh, Duffy, Kell, Kidd, and Lutheran antigens. Transfusion 1984; 24: 243-6.
  • 26 Gurevitch J, Nelken D. ABO groups in blood platelets. Nature 1954; 173: 356
  • 27 Cooling LL, Zhang DS, Walker KE. et al. Detection in human blood platelets of siall Lewis X gangliosides, potential ligands for CD62 and other selectins. Glycobiol 1995; 5: 571-81.
  • 28 Gardella JE, Ghiso J, Gorgone GA. et al. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochem Biophys Res Comm 1990; 173: 1292-8.
  • 29 Villarreal XC, Grant BW, Long GL. Demonstration of osteonectin mRNA in megakaryocytes: the use of the polymerase chain reaction. Blood 1991; 78: 1216-22.
  • 30 Tschopp J, Jenne DE, Hertig S. et al. Human megakaryocytes express clusterin and package it without apolipoprotein A-1 into α-granules. Blood 1993; 82: 118-25.
  • 31 Wartiovaara U, Salven P, Mikkola H. et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 1998; 80: 171-5.
  • 32 Colman RW. Where does platelet factor V originate?. Blood 1999; 93: 3152-3.
  • 33 Hayward CPM, Bainton DF, Smith JW. et al. Multimerin is found in the α-granules of resting platelets and is synthesized by a mega-karyocytic cell line. J Clin Invest 1993; 91: 2630-9.
  • 34 Hollestelle MJ, Thinnes T, Crain K. et al. Tissue distribution of factor VIII gene expression in vivo – a closer look. Thromb Haemost 2001; 86: 855-61.
  • 35 Taniguchi T, Ogasawara K, Takaoka A. et al. IFN family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623-55.
  • 36 Kim T, Kim TY, Song Y-H. et al. Activation of interferon regulatory factor 3 in response to DNA-damaging agents. J Biol Chem. 1999; 274: 30686-9.
  • 37 Navarro L, Mowen K, Rodems S. et al. Cytomegalovirus activates interferon immediate-response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol Cell Biol 1998; 18: 3796-3802.
  • 38 Grandvaux N, Servant MJ, tenOever B. et al. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvment in the regulation of interferon-stimulated genes. J Virol 2002; 76: 5532-9.
  • 39 Pabla R, Weyrich AS, Dixon DA. et al. Intergin-dependent control of translation: engagement of intergin αIIbβ3 regulates synthesis of proteins in activated human platelets. J Cell Biol 1999; 144: 175-84.
  • 40 Rosenwald IB, Pechet L, Han A. et al. Expression of translation initiation factors eIF-4E and eIF-2α°and a potential physiological role of continous protein synthesis in human platelets. Thromb Haemost 2001; 85: 142-51.